Biota to Acquire the Antibacterial Assets of MaxThera

News   Nov 13, 2009

 
Biota to Acquire the Antibacterial Assets of MaxThera
 
 
 

RELATED ARTICLES

Concept Life Sciences and Alderley Analytical Partner to provide Bioanalytical and DMPK Services

News

Companies announced they have signed a partnership agreement to provide high-value bioanalytical and DMPK study services.

READ MORE

Artificial Enzyme Can Catalyze Reactions

News

Artificial Biology has taken a step forward as a study shows the catalytic ability of a synthetic enzyme.

READ MORE

Patent Plausability Case Sees BIA Intervention

News

The UK Bioindustry Association (BIA) will intervene in a court case which could have huge ramifications for UK bioscience.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE